Medicines Co (MDCO) Reports Q2 Adj-EPS of 46c
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Selling, general and administrative: 69.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Selling, general and administrative: 69.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q2 adj-EPS of $0.46, GAAP EPS were $0.25, vs. the analyst estimate of $0.17. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $131.78 million.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
